Journal of Clinical Investigation · 2015 · 31 citations · 41 references
MedicineMolecular BiologyOncologyMetastasisSignal TransductionTumor ProgressionAngiogenesisAngiogenesis In CancerEndothelial ActivationGrowth Factor SignalingPeptide DeliveryTumor Microenvironment InteractionsAngiogenesis-driven GrowthEpsin ProteinsMurine ModelsTumor Vasculature TargetingTumor-targeting PeptidesVascular Endothelial Growth FactorVascular Endothelial Growth Factor Receptor SignalingVegfr Inhibitors
Tumor angiogenesis is critical for cancer progression. In multiple murine models, endothelium-specific epsin deficiency abrogates tumor progression by shifting the balance of VEGFR2 signaling toward uncontrolled tumor angiogenesis, resulting in dysfunctional tumor vasculature. Here, we designed a tumor endothelium-targeting chimeric peptide (UPI) for the purpose of inhibiting endogenous tumor endothelial epsins by competitively binding activated VEGFR2. We determined that the UPI peptide specifically targets tumor endothelial VEGFR2 through an unconventional binding mechanism that is driven by unique residues present only in the epsin ubiquitin-interacting motif (UIM) and the VEGFR2 kinase domain. In murine models of neoangiogenesis, UPI peptide increased VEGF-driven angiogenesis and neovascularization but spared quiescent vascular beds. Further, in tumor-bearing mice, UPI peptide markedly impaired functional tumor angiogenesis, tumor growth, and metastasis, resulting in a notable increase in survival. Coadministration of UPI peptide with cytotoxic chemotherapeutics further sustained tumor inhibition. Equipped with localized tumor endothelium-specific targeting, our UPI peptide provides potential for an effective and alternative cancer therapy.
41
K. Jin Kim, Bing Li, Jane Winer et al. · Nature · 1993 · 3.6K citations
Medicine, Cancer Biology, Oncology +14
Prostate cancer in a transgenic mouse.
Norman M. Greenberg, Francesco J. DeMayo, Milton J. Finegold et al. · Proceedings of the National Academy of Sciences · 1995 · 1.3K citations
Tissue-Penetrating Delivery of Compounds and Nanoparticles into Tumors
Kazuki N. Sugahara, Tambet Teesalu, Priya Karmali et al. · Cancer Cell · 2009 · 1.1K citations
Pharmacy, Oncology, Pharmaceutics +12
Coadministration of a Tumor-Penetrating Peptide Enhances the Efficacy of Cancer Drugs
Kazuki N. Sugahara, Tambet Teesalu, Priya Karmali et al. · Science · 2010 · 1.1K citations · Full text
Pharmacy, Oncology, Pharmacology +17